Novo Nordisk executive Dave Moore touted high interest in Wegovy's oral version of its injectable GLP-1 weight-loss ...

Wegovy’s oral version of its injectable weight-loss drug is seeing tremendous interest, Novo Nordisk executive Dave Moore ...

An Ozempic-style weight loss drug will be heavily subsidised for Australians with severe obesity and have experienced a cardiovascular event, like a heart attack or stroke.

Wegovy, a GLP‑1 medication similar to Ozempic, suppresses appetite and can lead to significant weight loss. Data from 2022 ...

Amazon Pharmacy maintains the requirement for a valid prescription as the central safeguard separating evidence-based medical ...

It's going to cost taxpayers a lot of money — but the federal government says subsidising weight loss drug Wegovy is an ...